April 2016 Although these medications have a legitimate and important role in the treatment of severe acute pain and some severe chronic pain conditions, it is clear that they are also overprescribed or prescribed without adequate safeguards and monitoring. Read More.
March 2016 A major milestone was reached on March 14, 2016, when the American Board of Medical Specialties (ABMS) formally announced recognition of the field of Addiction Medicine as a medical subspecialty. Read More.
March 2016 The brain is an organ that adapts in both short- and long-term ways to its environment, and prevention science over the past few decades has shown clearly that a person’s early experiences during the first few years of life and even prenatally can have an enormous impact on an individual’s later risk or resilience for drug abuse and related psychiatric conditions. Read More.
February 2016 Over the last four decades, NIDA-supported research has revolutionized our understanding of drug use and addiction, driving a new understanding of the neurobiological, genetic, epigenetic, social, and environmental factors that contribute to substance use disorders. Read More.
January 2016 By Dr. Nora Volkow (NIDA) and Dr. George Koob (NIAAA)- We have long expcted to see increasing substance use in middle and later life with the aging of baby boomers—a demographic that traditionally had a more relaxed attitude to substance use. A recent study funded by the National Institute on Aging reveals the unexpected enormity of the problem and its disastrous consequences for a generation of Americans. Read More.
December 2015 Revealing the results of the annual Monitoring the Future (MTF) survey of drug use and attitudes among American middle- and high-school students is an annual mid-December ritual at NIDA. This year the results were mostly positive, giving us cause for encouragement. Read More.
December 2015 A guest blog by Jeremy Waletzky, MD. Every year since 2003, NIDA has honored a young career scientist with the Society for Neuroscience Jacob P. Waletzky Memorial Award for Innovative Research in Drug Addiction and Alcoholism. This award would not be possible without the generosity of the Waletzky Family, who in memory of their son, wanted to recognize research contributions in the area of drug addiction or alcoholism, and the nervous system. Read More.
November 2015 The FDA announced its approval of the NARCAN Nasal Spray, an intranasal naloxone formula that can immediately restore normal breathing in a person overdosing on prescription opioids or heroin and thus save their life. Read More.
November 2015 Can the addictiveness of cigarettes be minimized by reducing their nicotine content? This idea was first proposed as a public health measure two decades ago, but when the Food and Drug Administration (FDA) argued the case before the Supreme Court in 2000, they were not granted the authority. Read More.